Arrhythmias

Contributing journals to this collection:
JAMA & Archives Journals

Citations 1-10 of 292 total displayed.

Most recent content

Editor's Correspondence
Optimal Anticoagulation Therapy in Patients With Valvular Heart Disease or Atrial Fibrillation

Christopher J. McLeod; Bernard J. Gersh
Arch Intern Med 2009; 169: 2032-a-2033-a. [Extract] [Full text] [PDF]  

Editor's Correspondence
The International Normalized Ratio Range of 2.0 to 3.0 Remains Appropriate for Atrial Fibrillation

Daniel E. Singer; Margaret C. Fang; Alan S. Go
Arch Intern Med 2009; 169: 2032. [Extract] [Full text] [PDF]  

Editor's Correspondence
Optimal Anticoagulation Therapy in Patients With Valvular Heart Disease or Atrial Fibrillation—Reply

Marieke Torn; Frits R. Rosendaal
Arch Intern Med 2009; 169: 2033. [Extract] [Full text] [PDF]  

Past content

The Rational Clinical Examination
Does This Patient With Palpitations Have a Cardiac Arrhythmia?

Paaladinesh Thavendiranathan; Akshay Bagai; Clarence Khoo; Paul Dorian; Niteesh K. Choudhry
JAMA 2009; 302: 2135-2143. [Abstract] [Full text] [PDF] [ eFigures and eTables ]  

Letters
Outcomes in Patients With Prolonged PR Interval or First-Degree Atrioventricular Block—Reply

Susan Cheng; Thomas J. Wang
JAMA 2009; 302: 1967-b-1968-b. [Extract] [Full text] [PDF]  

Letters
Outcomes in Patients With Prolonged PR Interval or First-Degree Atrioventricular Block

Vijay Arun Doraiswamy
JAMA 2009; 302: 1967-a. [Extract] [Full text] [PDF]  

Letters
Outcomes in Patients With Prolonged PR Interval or First-Degree Atrioventricular Block

Jaewon Oh; Ho Youn Won; Seok-Min Kang
JAMA 2009; 302: 1967. [Extract] [Full text] [PDF]  

Original Investigations
Glucocorticoid Use and Risk of Atrial Fibrillation or Flutter: A Population-Based, Case-Control Study

Christian Fynbo Christiansen; Steffen Christensen; Frank Mehnert; Steven R. Cummings; Roland D. Chapurlat; Henrik Toft Sørensen
Arch Intern Med 2009; 169: 1677-1683. [Abstract] [Full text] [PDF] [ eAppendix ]  

Editor's Correspondence
Adverse Events in Patients Receiving Cholinesterase Inhibitors Due to Dissimilar Follow-up Periods—Reply

Sudeep S. Gill; Chaim M. Bell; Paula A. Rochon
Arch Intern Med 2009; 169: 1724-a-1725-a. [Extract] [Full text] [PDF]  

Editor's Correspondence
Adverse Events in Patients Receiving Cholinesterase Inhibitors Due to Dissimilar Follow-up Periods

Mark Chan
Arch Intern Med 2009; 169: 1724. [Extract] [Full text] [PDF]  

[Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30